三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

  Home>News Center>Life
         
 

Cheap AIDS pill as good as pricey brands
(Agencies)
Updated: 2004-07-03 10:21

A cheap three-in-one generic AIDS pill from India is just as good as more expensive branded medicines and should be widely used in developing countries, researchers said on Friday.

Lack of scientific evidence about the clinical effectiveness of such generic fixed-dose combinations has until now caused some international AIDS donors to refuse to fund their use.

But a team from the French national agency for AIDS research and Swiss charity Medecins sans Frontieres said Cipla's Triomune performed as well as brand drugs in the first open clinical study in a developing country.

They found that 80 percent of HIV-infected patients given the tablet twice a day had undetectable levels of virus in their blood after six months treatment.

Results of the study involving 60 patients in Cameroon, 92 percent of whom had full-blown AIDS, were published in The Lancet medical journal.

“This generic fixed-dose combination (FDC) gives results comparable to those seen in the developed world using triple-drug therapy comprising brand name drugs,” said study co-ordinator Eric Delaporte.

“It is now no longer possible to raise scientific uncertainty as an objection to the widespread utilization of FDCs in the developing countries.”

In addition to being cheaper, drugs like Triomune -- which contains GlaxoSmithKline's lamivudine, Bristol-Myers Squibb's stavudine and Boehringer Ingelheim's nevirapine -- are simpler to use since patients need to take only two pills a day.

As such, they have a major role to play in meeting the World Health Organization's goal of getting antiretrovirals to three million people in the developing world by the end of 2005, N. Kumarasamy of the YRG Centre for AIDS Research and Education in Madras wrote in a commentary accompanying the research.

Controversy remains

The WHO has judged Triomune and another Indian combination called Triviro, from Ranbaxy Laboratories, to be safe and effective under a scheme that “prequalifies” them for use.

But both products -- which use compounds still covered by patents -- remain controversial.

Washington has barred groups receiving U.S. government funds from buying them, insisting only drugs approved by the Food and Drug Administration be used.

U.S. officials and Western pharmaceutical executives argue health providers are taking a risk by using medicines which have not passed the rigorous standards of the U.S. drugs watchdog.

Worries about the quality of Indian medicines were fuelled last month when the WHO removed two Cipla products -- though not Triomune -- from its prequalification list because they had not been proven to be equivalent to the original products.

Cipla says it is collecting data from new studies which should lead to the drugs being re-instated.

In Cameroon, where drugs are subsidized by the government, the cost of one month’s Triomune is $20, compared to $35 for the equivalent brand name therapy, even after heavy discounting by big pharmaceutical companies.

Elsewhere, cost differences can vary by as much as 100 percent, according to Medecins sans Frontieres.



Jackie Chan's new film 'The Myth'
CK over the top
Stephen Chow's kong fu to hit Mainland cinemas
  Today's Top News     Top Life News
 

Stress kills workaholic academics at young age

 

   
 

Efforts urged to curb floods, drought

 

   
 

China opposes foreign interference in HK

 

   
 

Ministry battles telecom price wars

 

   
 

UK indicts three in shell-fish drownings

 

   
 

Migrant workers given classes on AIDS

 

   
  Marlon Brando dies in Los Angeles hospital
   
  Apple plans new iMac, but delays shipment until Sept
   
  Fragrance makers hook up with Hollywood stars
   
  Piano maker tunes into China's growing middle class
   
  Nation hurries to salvage undersea cultural relics
   
  Panda smokes draw a crowd
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Feature  
  Oops! Britney to do marriage again  
Advertisement
         
主站蜘蛛池模板: 欧美精品无需播放器在线观看 | 国产在线成人精品 | 在线观看的黄网 | 欧美高清色视频在线播放 | 久久久久久久91精品免费观看 | 污污小视频在线观看 | 91一区二区视频 | 亚洲精品影院一区二区 | 国产精品嫩草视频永久网址 | 中文字幕日韩视频 | 国产香蕉国产精品偷在线观看 | 国产ppp在线视频在线观看 | 黄页网站 播放器 日本 | 毛片视频免费网站 | 欧美视屏在线观看 | 色性综合 | 成人永久免费高清 | 91天堂97年嫩模在线观看 | 日韩精品免费视频 | 亚洲国产成人精品不卡青青草原 | 尤物视频www | 爽爽爽爽爽爽a成人免费视频 | 国产精品亚洲综合天堂夜夜 | 久久精品视频7 | 欧美黄色视屏 | 国产小视频福利 | 免费永久国产在线视频 | 三级毛片免费看 | 国产成人精品三级 | 一区二区免费在线观看 | 欧美一级级a在线观看 | 免费黄色视屏 | 国产美女a做受大片在线观看 | 久久加久久| 毛片毛片毛片毛片毛片毛片 | 国产色婷婷视频在线观看 | 午夜激情在线视频 | 一级生活片 | 黄色一级免费网站 | 欧美精品久久 | 99精品国产兔费观看66 |